Skip to Content
Merck
  • Effect of thiazide treatment on biliary lipid composition in healthy volunteers.

Effect of thiazide treatment on biliary lipid composition in healthy volunteers.

European journal of clinical pharmacology (1989-01-01)
B Angelin
ABSTRACT

An increased incidence of cholecystitis has been observed in thiazide-treated patients. In order to test the possibility that the therapy might have caused an increase in the cholesterol saturation of gallbladder bile, biliary lipid composition was determined in fasting duodenal bile obtained from 10 healthy individuals after cholecystokinin injection, before and after 3 weeks of treatment with hydrochlorthiazide. The mean relative concentration of cholesterol was increased in 6 subjects, from 4.7 to 5.6 mol%, and the cholesterol saturation of bile was increased in 7, from 69 to 81%. These preliminary results indicate that thiazide treatment may to some extent increase biliary cholesterol saturation, and this may, at least in part, explain the higher prevalence of symptomatic gallbladder disease during such therapy.

MATERIALS
Product Number
Brand
Product Description

Supelco
Hydrochlorothiazide, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Hydrochlorothiazide, meets USP testing specifications
Sigma-Aldrich
Hydrochlorothiazide, crystalline
Supelco
Hydrochlorothiazide solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®